Cargando…
A Proposed Methodology for a Risk Assessment-Based Liposome Development Process
The requirements of a liposomal formulation vary depending on the pharmaceutical indication, the target patient population, and the corresponding route of administration. Different preparation methods require various material attributes (MAs) (properties and characteristics of the components) and pr...
Autores principales: | Németh, Zsófia, Pallagi, Edina, Dobó, Dorina Gabriella, Csóka, Ildikó |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760874/ https://www.ncbi.nlm.nih.gov/pubmed/33260443 http://dx.doi.org/10.3390/pharmaceutics12121164 |
Ejemplares similares
-
An Updated Risk Assessment as Part of the QbD-Based Liposome Design and Development
por: Németh, Zsófia, et al.
Publicado: (2021) -
Pharmaceutical Development and Design of Thermosensitive Liposomes Based on the QbD Approach
por: Dobó, Dorina Gabriella, et al.
Publicado: (2022) -
Quality-by-Design-Based Development of n-Propyl-Gallate-Loaded Hyaluronic-Acid-Coated Liposomes for Intranasal Administration
por: Sabir, Fakhara, et al.
Publicado: (2021) -
Quality by Design-Driven Zeta Potential Optimisation Study of Liposomes with Charge Imparting Membrane Additives
por: Németh, Zsófia, et al.
Publicado: (2022) -
Quality by Design Based Formulation Study of Meloxicam-Loaded Polymeric Micelles for Intranasal Administration
por: Sipos, Bence, et al.
Publicado: (2020)